281 related articles for article (PubMed ID: 25325127)
21. A global approach to hypertension.
van den Meiracker AH
EuroIntervention; 2013 May; 9 Suppl R():R16-20. PubMed ID: 23732150
[TBL] [Abstract][Full Text] [Related]
22. Risk-adjusted versus overall blood pressure control rate for identifying the need for intensified cardiovascular risk reduction: lessons from a cross-sectional study.
In der Schmitten J; Wegscheider K; Abholz HH; Mortsiefer A
Eur J Prev Cardiol; 2013 Dec; 20(6):972-9. PubMed ID: 23253744
[TBL] [Abstract][Full Text] [Related]
23. Hypertension Across the Atlantic: A Sprint or a Marathon?
Volpe M; Citoni B; Coluccia R; Battistoni A; Tocci G
High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):99-102. PubMed ID: 28451910
[No Abstract] [Full Text] [Related]
24. "Summer Dizziness" as a Neglected Phenomenon of Antihypertensive Drug Overuse in Patients With Carotid Disease: A Hypothesis.
Radak D; Tanaskovic S
Angiology; 2016 Oct; 67(9):797-8. PubMed ID: 26656500
[No Abstract] [Full Text] [Related]
25. A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patients.
García-Donaire JA; Segura J; Cerezo C; Ruilope LM
Blood Press; 2011 Dec; 20(6):322-34. PubMed ID: 21936729
[TBL] [Abstract][Full Text] [Related]
26. Treating blood pressure between 140/90 and 160/95 mmHg: no proven benefit.
Prescrire Int; 2014 Apr; 23(148):106. PubMed ID: 24860904
[TBL] [Abstract][Full Text] [Related]
27. "Treating hypertension" or "lowering blood pressure"? Extending the concept.
Chalmers J
Blood Press; 2002; 11(2):68-70. PubMed ID: 12035873
[No Abstract] [Full Text] [Related]
28. Clinical and translational science in cardiovascular research: highlights from the American Heart Association Scientific Sessions 2017: Changing view on the concept of cardiovascular risk and blood pressure targets.
Oikonomou EK
Cardiovasc Res; 2018 Jan; 114(1):e6-e8. PubMed ID: 29202178
[No Abstract] [Full Text] [Related]
29. Prehypertension: is it relevant for nephrologists?
Kaplan NM
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1381-3. PubMed ID: 19608711
[TBL] [Abstract][Full Text] [Related]
30. Assessing outcomes to determine whether symptoms related to hypertension justify renal artery stenting.
Modrall JG; Rosero EB; Timaran CH; Anthony T; Chung J; Valentine RJ; Trimmer C
J Vasc Surg; 2012 Feb; 55(2):413-9; discussion 419-20. PubMed ID: 22133456
[TBL] [Abstract][Full Text] [Related]
31. Drugs for hypertension.
Med Lett Drugs Ther; 2017 Mar; 59(1516):41-48. PubMed ID: 28263286
[No Abstract] [Full Text] [Related]
32. [Blood pressure parameters and cardiovascular risk in the elderly].
Blacher J; Henry O; Girerd X; Safar M
Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):489-93. PubMed ID: 12555371
[TBL] [Abstract][Full Text] [Related]
33. Calcium channel blocker.
Li CJ; Shi ZD
Clin Ther; 2010 Feb; 32(2):396; author reply 397. PubMed ID: 20206797
[No Abstract] [Full Text] [Related]
34. Mild hypertension in people at low risk.
Martin SA; Boucher M; Wright JM; Saini V
BMJ; 2014 Sep; 349():g5432. PubMed ID: 25224509
[No Abstract] [Full Text] [Related]
35. Modelling of blood pressure and total cardiovascular risk outcomes after second-line valsartan therapy: the BSCORE study.
Lins R; Coen N; Aerts A; Macdonald K; Brié H; Hermans C; Shen YM; Lee C; Vancayzeele S; Mecum N; Abraham I
Arch Cardiovasc Dis; 2011 Aug; 104(8-9):428-34. PubMed ID: 21944144
[TBL] [Abstract][Full Text] [Related]
36. Combined therapy in the treatment of hypertension.
Escobar C; Barrios V
Fundam Clin Pharmacol; 2010 Feb; 24(1):3-8. PubMed ID: 19682088
[TBL] [Abstract][Full Text] [Related]
37. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
Tempelhof MW
South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423
[No Abstract] [Full Text] [Related]
38. New onset diabetes during antihypertensive therapy.
Alderman MH
Am J Hypertens; 2008 May; 21(5):493-9. PubMed ID: 18437139
[TBL] [Abstract][Full Text] [Related]
39. The ACC/AHA and ESC/ESH Hypertension Guidelines: Contrasting Versions of Idiosyncratic Excellence.
Flack JM; Calhoun D
Am J Hypertens; 2019 Jul; 32(8):705-708. PubMed ID: 31314900
[No Abstract] [Full Text] [Related]
40. Shear stress as target to reduce atherosclerosis progression in hypertensive patients.
Marfella R; Bologna C; Quaranta E; Paolisso G
Am J Hypertens; 2008 Jul; 21(7):729. PubMed ID: 18584017
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
